Keeping Current
Targeted Therapies for NSCLC: Where Are We Today?
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:38:01
- More information
Informações:
Synopsis
Are you up to date with therapy strategies for ALK translocation and EGFR mutation–positive non-small cell lung cancer? Credit available for this activity expires: 9/10/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002896?ecd=bdc_podcast_libsyn_mscpedu